Pak Prayoga

733 total citations
9 papers, 302 citations indexed

About

Pak Prayoga is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Pak Prayoga has authored 9 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 3 papers in Computational Theory and Mathematics and 2 papers in Infectious Diseases. Recurrent topics in Pak Prayoga's work include Malaria Research and Control (9 papers), Mosquito-borne diseases and control (4 papers) and Computational Drug Discovery Methods (3 papers). Pak Prayoga is often cited by papers focused on Malaria Research and Control (9 papers), Mosquito-borne diseases and control (4 papers) and Computational Drug Discovery Methods (3 papers). Pak Prayoga collaborates with scholars based in Australia, Indonesia and United Kingdom. Pak Prayoga's co-authors include Ric N. Price, Enny Kenangalem, Nicholas M. Anstey, Ferryanto Chalfein, Kim A. Piera, Emiliana Tjitra, Jutta Marfurt, Qin Cheng, Jeanne Rini Poespoprodjo and Paulus Sugiarto and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Pak Prayoga

9 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pak Prayoga Australia 8 219 53 52 48 44 9 302
Prajesh K. Tyagi India 14 367 1.7× 52 1.0× 44 0.8× 55 1.1× 36 0.8× 18 453
Irene Handayuni Australia 13 259 1.2× 31 0.6× 35 0.7× 82 1.7× 23 0.5× 16 319
Louise Rodrigues Brazil 9 197 0.9× 25 0.5× 57 1.1× 39 0.8× 33 0.8× 16 284
Sara Brega France 8 294 1.3× 82 1.5× 68 1.3× 36 0.8× 51 1.2× 8 341
Varakorn Kosaisavee Thailand 7 308 1.4× 44 0.8× 18 0.3× 71 1.5× 57 1.3× 10 323
Alissa Myrick United States 10 215 1.0× 56 1.1× 114 2.2× 40 0.8× 18 0.4× 13 356
Dipak Kumar Raj United States 9 298 1.4× 68 1.3× 80 1.5× 62 1.3× 17 0.4× 19 369
Panita Gosi Thailand 12 329 1.5× 38 0.7× 47 0.9× 105 2.2× 39 0.9× 21 405
Araia Berhane Eritrea 9 345 1.6× 58 1.1× 28 0.5× 68 1.4× 24 0.5× 18 401
Annie N. Cowell United States 9 240 1.1× 62 1.2× 83 1.6× 76 1.6× 14 0.3× 13 363

Countries citing papers authored by Pak Prayoga

Since Specialization
Citations

This map shows the geographic impact of Pak Prayoga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pak Prayoga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pak Prayoga more than expected).

Fields of papers citing papers by Pak Prayoga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pak Prayoga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pak Prayoga. The network helps show where Pak Prayoga may publish in the future.

Co-authorship network of co-authors of Pak Prayoga

This figure shows the co-authorship network connecting the top 25 collaborators of Pak Prayoga. A scholar is included among the top collaborators of Pak Prayoga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pak Prayoga. Pak Prayoga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Prayoga, Pak, Leo Leonardo, Enny Kenangalem, et al.. (2023). Case Report: Severe Plasmodium vivax Malaria after Splenectomy. American Journal of Tropical Medicine and Hygiene. 109(2). 284–287. 2 indexed citations
2.
Kho, Steven, Gabriela Minigo, Benediktus Andries, et al.. (2018). Circulating Neutrophil Extracellular Traps and Neutrophil Activation Are Increased in Proportion to Disease Severity in Human Malaria. The Journal of Infectious Diseases. 219(12). 1994–2004. 49 indexed citations
3.
Wirjanata, Grennady, Irene Handayuni, Pak Prayoga, et al.. (2017). Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes. Antimicrobial Agents and Chemotherapy. 61(8). 30 indexed citations
4.
Wirjanata, Grennady, Irene Handayuni, Sophie Zaloumis, et al.. (2016). Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms. Malaria Journal. 15(1). 137–137. 10 indexed citations
5.
Wirjanata, Grennady, Irene Handayuni, Pak Prayoga, et al.. (2015). Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry. Malaria Journal. 14(1). 417–417. 13 indexed citations
6.
Marfurt, Jutta, Ferryanto Chalfein, Pak Prayoga, et al.. (2012). Comparative Ex Vivo Activity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparum and P. vivax. Antimicrobial Agents and Chemotherapy. 56(10). 5258–5263. 32 indexed citations
7.
Marfurt, Jutta, Ferryanto Chalfein, Pak Prayoga, et al.. (2011). Ex Vivo Drug Susceptibility of Ferroquine against Chloroquine-Resistant Isolates of Plasmodium falciparum and P. vivax. Antimicrobial Agents and Chemotherapy. 55(9). 4461–4464. 30 indexed citations
8.
Marfurt, Jutta, Ferryanto Chalfein, Pak Prayoga, et al.. (2010). Ex VivoActivity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates ofPlasmodium falciparumandP. vivax. Antimicrobial Agents and Chemotherapy. 55(3). 961–966. 37 indexed citations
9.
Russell, Bruce, Ferryanto Chalfein, Budi Prasetyorini, et al.. (2008). Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax. Antimicrobial Agents and Chemotherapy. 52(3). 1040–1045. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026